The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Pignon, J.-P., Maître, A. L., Maillard, E., & Bourhis, J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.04.014 · Cited by 3,069
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
Vermorken, J. B., Remenar, E., van Herpen, C., Gorlia, T., Mesia, R., Degardin, M., Stewart, J. S., Jelic, S., Betka, J., Preiss, J. H., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071028 · Cited by 1,719
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Posner, M. R., Hershock, D. M., Blajman, C. R., Mickiewicz, E., Winquist, E., Gorbounova, V., Tjulandin, S., Shin, D. M., Cullen, K., Ervin, T. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070956 · Cited by 1,705
Lefebvre, J.-L., Chevalier, D., Luboinski, B., Kirkpatrick, A., Collette, L., & Sahmoud, T. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.13.890 · Cited by 1,334
Recent Advances in Head and Neck Cancer
Haddad, R. I., & Shin, D. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707975 · Cited by 916
Brockstein, B., Haraf, D. J., Rademaker, A. W., Kies, M. S., Stenson, K. M., Rosen, F., Mittal, B. B., Pelzer, H., Fung, B. B., Witt, M.-E., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh308 · Cited by 370
How Do Head and Neck Cancer Patients Prioritize Treatment Outcomes Before Initiating Treatment?
List, M. A., Stracks, J., Colangelo, L., Butler, P., Ganzenko, N., Lundy, D., Sullivan, P., Haraf, D., Kies, M., Goodwin, W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.877 · Cited by 197
Posner, M. R., Haddad, R. I., Wirth, L. J., Norris, C. M., Goguen, L. A., Mahadevan, A., Sullivan, C. A., & Tishler, R. B. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.007 · Cited by 82
Paccagnella, A., Mastromauro, C., D'Amanzo, P., & Ghi, M. G. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-s3-08 · Cited by 27
Cited by
Machiels, J.-P., René Leemans, C., Golusinski, W., Grau, C., Licitra, L., & Gregoire, V. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.07.011 · Cited by 916
Lacas, B., Carmel, A., Landais, C., Wong, S. J., Licitra, L., Tobias, J. S., Burtness, B., Ghi, M. G., Cohen, E. E. W., Grau, C., et al. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.01.013 · Cited by 389
Self-citationJelinek, M. J., Foster, N. R., Zoroufy, A. J., Schwartz, G. K., Munster, P. N., Seiwert, T. Y., de Souza, J. A., & Vokes, E. E. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2020.105171 · Cited by 20
“, 28% in Hitt et al.[4, 5, 9] Similarly, among the 15 patients who started chemoradiation after completing induction therapy, 87% remained compliant to the entirety of the definitive chemoradiation course which is comparable to these historical induction trials.”
Result
Metadata
- Authors
- Hitt, R., Grau, J. J., López-Pousa, A., Berrocal, A., García-Girón, C., Irigoyen, A., Sastre, J., Martínez-Trufero, J., Brandariz Castelo, J. A., Verger, E., Cruz-Hernández, J. J., Almodóvar, C., Cortés-Funes, H., Escobar, Y., Fonseca-Sánchez, E., Galcerán, J. C., Guix, M., Isla-Casado, D., Jara-Sánchez, C., Leitão-Silva, M. R., Mel-Lorenzo, J. R., Pastor-Borgoñón, M., Pastor-Gaitán, P., Rodríguez-Jaráiz, A., Millán, J. M., Satrustegui-Galdona, J., Moreno, M., Estefanía, E., Santiago, E., & García, J. J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 25
- Issue
- 1
- Pages
- 216-225
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2118938219
- Cited by
- 353
- References
- 10
- FWCI
- 26.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. https://app.cochat.ai/papers/10.1093/annonc/mdt461
- The paper
- Hitt, R., Grau, J. J., López-Pousa, A., Berrocal, A., García-Girón, C., Irigoyen, A., Sastre, J., Martínez-Trufero, J., Brandariz Castelo, J. A., Verger, E., Cruz-Hernández, J. J., Almodóvar, C., Cortés-Funes, H., Escobar, Y., Fonseca-Sánchez, E., Galcerán, J. C., Guix, M., Isla-Casado, D., Jara-Sánchez, C., . . . García, J. J. (2014). A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer. Annals of Oncology. https://doi.org/10.1093/annonc/mdt461
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.